Your browser doesn't support javascript.
loading
Tubal primary metastatic choriocarcinoma coexistent with a viable early pregnancy: a case report.
Cianci, Stefano; Vitale, Salvatore Giovanni; Tozzi, Roberto; Cignini, Pietro; Padula, Francesco; D'Emidio, Laura; Mangiafico, Lucia; Giorlandino, Claudio; Frigerio, Luigi; Rossetti, Diego; Caruso, Salvatore.
Afiliação
  • Cianci S; Department of Medical Surgical Specialties, University of Catania, Catania, Italy.
  • Vitale SG; Department of Medical Surgical Specialties, University of Catania, Catania, Italy.
  • Tozzi R; Department of Gynecologic Oncology, Oxford Cancer Centre, Oxford University Hospital.
  • Cignini P; Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy.
  • Padula F; Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy.
  • D'Emidio L; Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy.
  • Mangiafico L; Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy.
  • Giorlandino C; Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy.
  • Frigerio L; Division of Gynecology and Obstetrics, Ospedale Papa Giovanni XXIII, Milano Bicocca University, Bergamo, Italy.
  • Rossetti D; Division of Gynecology and Obstetrics, Ospedale Papa Giovanni XXIII, Milano Bicocca University, Bergamo, Italy.
  • Caruso S; Department of Medical Surgical Specialties, University of Catania, Catania, Italy.
J Prenat Med ; 8(3-4): 47-9, 2014.
Article em En | MEDLINE | ID: mdl-26266001
ABSTRACT

INTRODUCTION:

fallopian tube choriocarcinoma coexistent with viable intrauterine pregnancy is an extremely rare condition. CASE REPORT we present the first case reported in literature of tubal choriocarcinoma coexistent with viable intrauterine pregnancy detected at early gestational age (20 weeks) and successfully managed by seriate monitoring of maternal and fetal health status until 31 weeks, then treated by cesarean section followed by etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) chemotherapy protocol.

CONCLUSIONS:

the outcome was favorable for both the mother and her fetus.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Prenat Med Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Prenat Med Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália